Annex II · Annex III

MDR technical documentation under Annex II and Annex III

MDR technical documentation is the set of documents a manufacturer must draw up and keep up to date to show that a device conforms to Regulation (EU) 2017/745. Annex II lists the content: device description and specification, information supplied by the manufacturer, design and manufacturing information, the GSPR, benefit-risk analysis and risk management, and product verification and validation. Annex III adds the technical documentation on post-market surveillance: the PMS plan and the PSUR or PMS report. This page maps each part to the place it lives in MDRpilot.

Who it is for

  • Teams who need to know what goes into each section
  • Manufacturers checking a legacy file against MDR
  • Reviewers preparing an internal pre-submission check

Key capabilities

  • Section map

    Annex II and III sections with status, so missing parts are listed rather than discovered.

  • Classification rationale

    The Annex VIII assistant stores the rule and reasoning on the product, ready for section II.1.

  • Verification evidence

    Test reports are read for a pass or fail verdict; passing reports can verify risk controls and support GSPR rows.

  • PMS documentation

    Annex III documents are part of the same product record.

Annex II and III section by section

Annex sectionContent and where it lives in MDRpilot
II.1 Device description and specificationIntended purpose, users, principles of operation, variants, accessories, classification rationale, Basic UDI-DI. Product record and Annex VIII assistant.
II.2 Information supplied by the manufacturerLabels and IFU in the languages of the target markets. IFU module and label export.
II.3 Design and manufacturing informationDesign stages, manufacturing processes and their validation, sites and critical suppliers. Technical file section, design control records, supplier evaluation.
II.4 General safety and performance requirementsApplicability of each Annex I requirement, justification, methods, standards and evidence. GSPR module.
II.5 Benefit-risk analysis and risk managementBenefit-risk analysis under Annex I Sections 1 and 8 and the risk management solutions under Section 3. ISO 14971 risk file.
II.6 Product verification and validationPre-clinical tests (biocompatibility, electrical safety, software, stability, packaging, sterilisation) and the clinical evaluation. Evidence files and clinical module.
III PMS planData collection, indicators and thresholds, complaint and trend handling, PMCF. PMS module.
III PSUR or PMS reportPeriodic summary of post-market data and conclusions. PSUR/PMS report outline by class.

Common weaknesses reviewers find

Each of these is a cross-reference problem. MDRpilot reduces them by drawing the device description from one record, by linking evidence to GSPR rows and risk controls, and by flagging dependent documents when the product data changes.

  • Device description and IFU describe different intended purposes or user groups
  • GSPR rows marked applicable with a standard listed but no test report attached
  • Risk controls without evidence that the control was verified
  • Clinical evaluation that does not cover every indication claimed in the IFU
  • PMS plan with no measurable indicators or thresholds

How the workflow runs

  1. 1

    Start from the product

    Complete the device description once.

  2. 2

    Work Annex I

    Decide applicability and methods for each GSPR.

  3. 3

    Attach evidence

    Upload verification and validation reports and confirm links.

  4. 4

    Complete Annex III

    Write the PMS plan and schedule the PSUR or PMS report.

Connected to the rest of the file

MDRpilot is not a stand-alone document generator. Requirements, evidence and documents share one product record.

  1. Requirements
  2. Evidence
  3. Documents
  4. Risk
  5. Clinical
  6. PMS
  7. QMS
  8. Audit

Each step reads from the same product record. A test report linked to a GSPR row can verify a risk control, a change to the device class flags the documents that depend on it, and the audit readiness view counts what is still open across all of them.

Limitations

  • This map follows the MDR text. Device-specific requirements such as those for software, devices with a medicinal substance or devices made with animal tissue need additional sections that your team must define.
  • MDRpilot does not decide grouping of devices or applicability of requirements; it records your decisions and their justification.

MDRpilot is documentation and workflow software. It is not a medical device, not a notified body and not a regulatory authority. It does not certify devices or guarantee compliance; AI-generated drafts must be reviewed and approved by qualified people in the manufacturer's organisation.

Frequently asked questions

What is the difference between Annex II and Annex III?

Annex II covers the technical documentation of the device itself. Annex III covers the technical documentation on post-market surveillance, namely the PMS plan and the PSUR or PMS report.

Is the technical documentation the same as the design history file?

No. The design history file is a design control record. The MDR technical documentation draws on it, especially in section II.3 and II.6, but has a wider scope.

Must the technical documentation be in a specific language?

The language is agreed with the notified body and must be acceptable to it. Labels and IFU must be in the languages required by the Member States where the device is made available.

How often must the technical documentation be updated?

Article 10 requires it to be kept up to date. Updates follow design changes, new standards, PMS findings and clinical evaluation updates.

Can MDRpilot check my Annex II file for gaps?

Yes. Section status, GSPR evidence links and the readiness view show where content or evidence is missing. Whether the content is adequate remains a judgement for your team and your notified body.

References

  1. Regulation (EU) 2017/745 on medical devices (MDR) — EUR-Lex, Publications Office of the European Union.
  2. Guidance: MDCG endorsed documents and other guidance — European Commission.

Always check the consolidated text of the regulation and the current version of each guidance document before relying on it.

See it with your own device

Create an account, add your company and one real device. The Suite demo runs for 3 days and the first procedure opens straight away, not an empty dashboard.